ANTIPODES PARTNERS Ltd: VLRS position timeline
Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of ANTIPODES PARTNERS Ltd on VLRS, newest first. How the timeline and the estimate are built.
ANTIPODES PARTNERS Ltd held 65,647 VLRS shares at 2026-06-30 per its 13F-HR filed 2026-08-06.
the latest 13F is the newest step
- period ended2026-06-3013F 65,647 sharesChange vs previous 13F -172,675 shares
0.01% of the 13F portfolio, value $615,112.
13F-HR 0001652442-26-000005 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2026-03-3113F 238,322 sharesChange vs previous 13F +60,377 shares
0.03% of the 13F portfolio, value $1,725,451.
13F-HR 0001652442-26-000004 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-12-3113F 177,945 sharesChange vs previous 13F +132,973 shares
0.03% of the 13F portfolio, value $1,580,270.
13F-HR 0001652442-26-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-09-3013F 44,972 sharesChange vs previous 13F +44,972 shares
0.01% of the 13F portfolio, value $322,923.
13F-HR 0001652442-25-000007 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2025-03-3113F 0 sharesChange vs previous 13F -209,934 shares
13F-HR 0001652442-25-000003 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
Exited: the 13F for this period no longer lists the position.
- period ended2024-12-3113F 209,934 sharesChange vs previous 13F -654,220 shares
0.05% of the 13F portfolio, value $1,562,035.
13F-HR 0001652442-25-000002 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).
- period ended2024-09-3013F 864,154 sharesChange vs previous 13F not available
0.19% of the 13F portfolio, value $5,470,489.
13F-HR 0001652442-24-000006 filed by ANTIPODES PARTNERS Ltd
Filed (acceptance time not in the bulk data set), ingestedAcceptance time not in the bulk data set (spec §4.2).